Compare Organon Pharma Indonesia Tbk. (SCPI) vs Wijaya Karya Bangunan Gedung Tbk. (WEGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Wijaya Karya Bangunan Gedung Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Wijaya Karya Bangunan Gedung Tbk. trades at Rp50 (market cap 488.17B, 44.92M 24h volume). The key difference: Wijaya Karya Bangunan Gedung Tbk. is far larger — about 4.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | WEGE | |
|---|---|---|
Market Cap | 104.4B | 488.17B |
Volume | — | 44.92M |
Lot | — | 449.16K |
Turnover | — | 2.25B |
Average Price | — | 50.18 |
Value | — | 2.25B |
Indicative Equilibrium Price | — | 50 |
Indicative Equilibrium Volume | — | 3.49K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Wijaya Karya Bangunan Gedung Tbk.
PT Wijaya Karya Bangunan Gedung Tbk (the Company) is located in South Jakarta, DKI Jakarta was established by Deed No. 43, October 24, 2008 made before Imas Fatimah, SH., Notary in Jakarta.
Read more on WEGE →
